共 22 条
- [1] Nishimura K., Miyawaki N., Yamauchi H., Iso T., Tissue selectivity of the novel calcium antagonist sesamodil fumarate in isolated smooth muscles and cardiac muscles, Arzneimitt Forsch (Drug Res), 40, pp. 244-248, (1990)
- [2] Taira N., Effects of diltiazem and other calcium-antagonists on cardiac functions and coronary blood flow as assessed in blood-perfused dog-heart preparations, New Drug Therapy with a Calcium Antagonist: Diltiazem Hakone Symposium '78, pp. 91-103, (1979)
- [3] Taira N., Differences in cardiovascular profile among calcium antagonists, The American Journal of Cardiology, 59, pp. 24B-29B, (1987)
- [4] Kawada M., Satoh K., Taira N., Profile of coronary vasodilator and cardiac actions of bepridil revealed by use of isolated, blood-perfused heart preparations of the dog, J Cardiovasc Pharmacol, 5, pp. 604-612, (1983)
- [5] Taira N., Kawada M., Satoh K., Cardiac versus coronary vasodilator actions of KB-944, a new calcium antagonist, assessed in isolated, blood-perfused heart preparations of dogs, J Cardiovasc Pharmacol, 5, pp. 359-356, (1983)
- [6] Hosono M., Taira N., coronary vasodilator versus cardiac effects of MCI-176, a novel quinazolinone calcium antagonist, in the dog heart, J Cardiovasc Pharmacol, 9, pp. 633-640, (1987)
- [7] Kubota K., Hashimoto K., Selective stimulation of the parasympathetic preganglionic nerve fibres in the excised and blood-perfused SA node preparation of the dog, Naunyn Schmiedebergs Arch Pharmacol, 278, pp. 135-150, (1973)
- [8] Hashimoto K., Iijima T., Hashimoto K., Taira N., The isolated and cross-circulated AV node preparation of the dog, Tohoku J Exp Med, 107, pp. 263-275, (1972)
- [9] Endoh M., Hashimoto K., Pharmacological evidence of autonomic nerve activities in canine papillary muscle, Am J Physiol, 218, pp. 1459-1463, (1970)
- [10] Litchfield J.T., Wilcoxon F., A simplified method of evaluating dose-effect experiments, J Pharmacol Exp Ther, 96, pp. 99-113, (1949)